TECNIFAR-INDÚSTRIA TÉCNICA FARMACÊUTICA, S.A.;TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, SA;TECNIFAR-INDÚSTRIA TÉCNICA FARMACÊUTICA; S.A.
发明人:
DA COSTA GARCIA, MIGUEL ÂNGELO,SOUSA DE SÃO JOSÉ, CARLOS JORGE,RODRIGUES LEANDRO, CLARA ISABEL,RODRIGUES PARDAL DIAS ANTUNES MARÇAL DA SILVA, FILIPA MARIA,MARTINS BARBOSA, ANA RAQUEL
申请号：
SG2013019385
公开号：
SG188566A1
申请日:
2011.09.19
申请国别(地区):
SG
年份:
2013
代理人:
摘要：
The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophage F387/08, F391/08, F394/08, F488/08, F510/08, F44/10, and F125/10, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophage and/or isolated polypeptides, as well as to methods for the treatment and prevention of bacterial infections using same, either alone or in combination with other antibacterial therapies, e.g., antibiotics and/or other phage therapies.
